Nicobrevin for smoking cessation
© 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Background: Nicobrevin is a proprietary product marketed as an aid to smoking cessation. It contains quinine, menthyl valerate, camphor and eucalyptus oil. Objectives: The objective of this review was to assess the effects of Nicobrevin on long-term smoking cessation Search methods: We searched the Cochrane Tobacco Addiction Group trials register. Most recent search was January 2009. Selection criteria: Randomized trials comparing Nicobrevin to placebo or an alternative therapeutic control, which reported smoking cessation with at least six months follow up. Data collection and analysis: Data were sought on the outcome, method of randomisation, and completeness of follow up. Main results: We identified no trials meeting the full inclusion criteria including long-term follow-up. Authors' conclusions: There is no evidence available from long-term trials that Nicobrevin can aid smoking cessation.